Advancing cell therapy for neurodegenerative diseases

S Temple - Cell stem cell, 2023 - cell.com
Cell-based therapies are being developed for various neurodegenerative diseases that
affect the central nervous system (CNS). Concomitantly, the roles of individual cell types in …

Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system

M Strzelec, J Detka, P Mieszczak… - Frontiers in …, 2023 - frontiersin.org
In recent years, there has been a tremendous development of biotechnological,
pharmacological, and medical techniques which can be implemented in the functional …

An in vivo model of functional and vascularized human brain organoids

AAF Mansour, JT Gonçalves, CW Bloyd, H Li… - Nature …, 2018 - nature.com
Differentiation of human pluripotent stem cells to small brain-like structures known as brain
organoids offers an unprecedented opportunity to model human brain development and …

Multimodal monitoring of human cortical organoids implanted in mice reveal functional connection with visual cortex

MN Wilson, M Thunemann, X Liu, Y Lu, F Puppo… - Nature …, 2022 - nature.com
Human cortical organoids, three-dimensional neuronal cultures, are emerging as powerful
tools to study brain development and dysfunction. However, whether organoids can …

Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector

C Wang, R Najm, Q Xu, D Jeong, D Walker… - Nature medicine, 2018 - nature.com
Efforts to develop drugs for Alzheimer's disease (AD) have shown promise in animal studies,
only to fail in human trials, suggesting a pressing need to study AD in human model …

Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus

Q Long, D Upadhya, B Hattiangady… - Proceedings of the …, 2017 - National Acad Sciences
Status epilepticus (SE), a medical emergency that is typically terminated through
antiepileptic drug treatment, leads to hippocampus dysfunction typified by …

[HTML][HTML] Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy

C Lentini, M d'Orange, N Marichal, MM Trottmann… - Cell stem cell, 2021 - cell.com
Reprogramming brain-resident glial cells into clinically relevant induced neurons (iNs) is an
emerging strategy toward replacing lost neurons and restoring lost brain functions. A …

Nav1. 1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer's disease

M Martinez-Losa, TE Tracy, K Ma, L Verret… - Neuron, 2018 - cell.com
Inhibitory interneurons regulate the oscillatory rhythms and network synchrony that are
required for cognitive functions and disrupted in Alzheimer's disease (AD). Network …

Extracellular vesicles from human iPSC-derived neural stem cells: miRNA and protein signatures, and anti-inflammatory and neurogenic properties

R Upadhya, LN Madhu, S Attaluri… - Journal of …, 2020 - Taylor & Francis
Grafting of neural stem cells (NSCs) derived from human induced pluripotent stem cells
(hiPSCs) has shown promise for brain repair after injury or disease, but safety issues have …

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease

R Najm, EA Jones, Y Huang - Molecular neurodegeneration, 2019 - Springer
Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease (AD),
increasing risk and decreasing age of disease onset. Many studies have demonstrated the …